The prerequisite is that the European Medicines Agency EMA approves the active ingredient. A corresponding application was submitted last week.
According to the fund, delivery to the EU would be possible once a large part of the mass vaccination in Russia is completed. The vaccinations have been running since December. According to the latest figures, more than 1.5 million people have received the two-component vaccine. According to the information, Sputnik V is now registered in 15 countries. Last week, Hungary was the first EU country to order two million doses of the Russian preparation.
The active ingredient was the first in the world to be released for broad use in the population in mid-August, although important tests had passed by then. This triggered international criticism. No independent studies are known to date. The British-Swedish pharmaceutical company AstraZeneca is struggling with production problems.
–
–
